London’s benchmark index edged higher on Monday as rising oil prices driven by Middle East supply disruptions lifted sentiment across UK markets. The FTSE 100 gained 0.53% as of 03:15 ET, while
London’s benchmark index edged higher on Monday as rising oil prices driven by Middle East supply disruptions lifted sentiment across UK markets. The FTSE 100 gained 0.53% as of 03:15 ET, while
MoreThe S&P 500 remains a closely watched benchmark for global investors, with daily movements reflecting broader sentiment across equities markets in the United States. Futures trading ahead of each session gives investors
MoreJapan’s SoftBank (9984.T), one of OpenAI’s biggest investors, plunged as much as 13 per cent in Tokyo trading on Monday amid a broad technology sector selloff. Memory chip maker Kioxia dropped as
MoreBrent crude climbed sharply toward $108 per barrel on Monday morning, reaching its highest level in four months after a significant supply disruption in the Middle East. Saudi Arabia shut a major
MoreSenate Bill 867, signed by Governor Newsom, marks California’s first attempt to regulate AI-companion functionality built directly into children’s toys. The law prohibits any person from manufacturing, selling, exchanging, or offering for
MoreMissouri Republicans are continuing their legal push to defend a contested electoral map, despite repeated rejections from the United States Supreme Court. The Supreme Court has consistently turned away Missouri’s attempts to
MoreGlobal equity futures retreated in early trading as investors responded to fresh concerns surrounding the artificial intelligence sector, putting pressure on major indices. The warning signs emerging from AI-related stocks have prompted
MoreLondon’s benchmark FTSE 100 index fell under pressure as rising oil prices driven by US-Iran tensions continued to unsettle global markets. Crude prices remained above the $100 per barrel mark, a level
MoreGSK secured FDA approval for Jideytro, known scientifically as zidesamtinib, marking the British pharmaceutical giant’s first-ever commercial lung cancer treatment. The approval came roughly two months ahead of the FDA’s original target
MoreOn August 31, the Securities and Exchange Commission and the Food and Drug Administration signed a memorandum of understanding to formalise cross-agency sharing of non-public information. The agreement places particular emphasis on
More
